Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mastrapasqua

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 1, 1979
[Oro-pharyngeal oesophagus papillomatosis. Description of one case (author's transl)]C Ruffato, L Buttazzoni, G P Mazzoleni, et al.
Minerva Medica|March 15, 1987
[Chemical and cytologic tests in the differential diagnosis of ascites]A Attanasio, I Castellaro, G Zappalà, et al.
Minerva Cardioangiologica|May 1, 1990
[Pharmacologic effects and safety profile of bethanechol in the differential diagnosis of pseudo-anginal thoracic pain]G Mastrapasqua, L Bonavina, M Anselmino, et al.
Oncology Reports|May 20, 2011
Feasibility of intra-arterial chemotherapy followed by chemoembolization, every 28 days, in unresectable hepatocellular carcinomaM Colleoni, G Liessi, G Mastrapasqua, et al.
Minerva Gastroenterologica E Dietologica|June 1, 1993
[Ischemic hepatitis. Description of 4 cases and review of the literature]G Mastrapasqua, A Scapinello, D Madia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Intra-arterial chemotherapy followed by chemo-embolisation in unresectable hepatocellular carcinomaM Colleoni, G Liessi, G Mastrapasqua, et al.
Oncology Reports|May 19, 2011
Prognostic factors in patients with hepatocellular carcinoma submitted to chemoembolizationM Colleoni, G Liessi, G Mastrapasqua, et al.
International Journal of Oncology|May 5, 2011
Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinomaM Colleoni, M Biasin, L Boni, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|March 1, 1979
[Oro-pharyngeal oesophagus papillomatosis. Description of one case (author's transl)]C Ruffato, L Buttazzoni, G P Mazzoleni, et al.
Minerva Medica|March 15, 1987
[Chemical and cytologic tests in the differential diagnosis of ascites]A Attanasio, I Castellaro, G Zappalà, et al.
Minerva Cardioangiologica|May 1, 1990
[Pharmacologic effects and safety profile of bethanechol in the differential diagnosis of pseudo-anginal thoracic pain]G Mastrapasqua, L Bonavina, M Anselmino, et al.
Oncology Reports|May 20, 2011
Feasibility of intra-arterial chemotherapy followed by chemoembolization, every 28 days, in unresectable hepatocellular carcinomaM Colleoni, G Liessi, G Mastrapasqua, et al.
Minerva Gastroenterologica E Dietologica|June 1, 1993
[Ischemic hepatitis. Description of 4 cases and review of the literature]G Mastrapasqua, A Scapinello, D Madia, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Intra-arterial chemotherapy followed by chemo-embolisation in unresectable hepatocellular carcinomaM Colleoni, G Liessi, G Mastrapasqua, et al.
Oncology Reports|May 19, 2011
Prognostic factors in patients with hepatocellular carcinoma submitted to chemoembolizationM Colleoni, G Liessi, G Mastrapasqua, et al.
International Journal of Oncology|May 5, 2011
Prognostic value of proliferating cell nuclear antigen (PCNA) expression in unresectable hepatocellular carcinomaM Colleoni, M Biasin, L Boni, et al.
Pageof 1